MEDICAMEQ — Medicamen Biotech Balance Sheet
0.000.00%
- IN₹5.59bn
- IN₹5.73bn
- IN₹1.79bn
- 80
- 12
- 60
- 51
Annual balance sheet for Medicamen Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17.1 | 16.6 | 38.2 | 208 | 148 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 773 | 791 | 848 | 887 | 789 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 1,041 | 960 | 1,230 | 1,634 | 1,596 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 739 | 894 | 921 | 918 | 910 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 1,813 | 1,940 | 2,257 | 2,785 | 2,946 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 565 | 533 | 727 | 826 | 846 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 601 | 611 | 792 | 851 | 876 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 1,212 | 1,329 | 1,465 | 1,934 | 2,070 |
Total Liabilities & Shareholders' Equity | 1,813 | 1,940 | 2,257 | 2,785 | 2,946 |
Total Common Shares Outstanding |